Carregant...
Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β
Vaccinia virus (VV) has been used extensively as a vaccine vehicle in the clinical application for infectious diseases and cancer. Previous studies have suggested that the unique potency of VV-based vaccine lies in its effective activation of the innate immune system. However, how VV activates innat...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1785085/ https://ncbi.nlm.nih.gov/pubmed/16973959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-027136 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|